SynthesisJournal of biomedical optics2025
Advancements in broadband near-infrared spectroscopy instrumentation for the assessment of
Synthesis in Journal of biomedical optics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- OptoCENTAL: a standardized, bench-testing platform based on phantoms for validating optical systems aimed at clinical monitoring of the placenta.Journal of biomedical optics · 2026Article
- The Effectiveness of NIRS-Based Wearable Devices in Estimating Physical Activity Intensity in Patients with Chronic Non-Communicable Diseases: A Structured Narrative Review.Medical sciences (Basel, Switzerland) · 2026Review
- Introduction to Special Issue on Metabolic Imaging and Spectroscopy, 2025.Journal of biomedical optics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Broadband near-infrared spectroscopy (bNIRS) provides a noninvasive, nonionizing method for measuring oxidative metabolism through monitoring of cytochrome- Aim: We catalog and compare bNIRS systems developed over the past 37 years, focusing on hardware configurations, component choices, and trends toward miniaturization and multichannel measurements. Approach: A systematic literature review was conducted using Web of Science and citation mapping tools. Inclusion criteria targeted systems utilizing broadband light sources and spectrometers, covering a spectral range of 600 to 1000 nm, and capable of measuring CCO concentration changes. A total of 72 articles were reviewed. Results: The quartz tungsten halogen lamp and commercial bench-top spectrometers remain dominant in bNIRS developments. Recent advancements include fiber-optic innovations and compact charge-coupled device (CCD) based sensors, facilitating multichannel configurations. However, no fully commercial portable bNIRS device exists. The recent addition of micro form factor spectrometers drives the emerging trend toward wearable designs. Conclusions: Future bNIRS devices must prioritize miniaturization, ease of use, and cost reduction to support clinical translation. Emerging photonic technologies offer promising pathways for compact, wearable bNIRS systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.